NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma - NICE TAG TA319

Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma - NICE TAG TA319

1.1 Ipilimumab is recommended, within its marketing authorisation, as an option for treating adults with previously untreated advanced (unresectable or metastatic) melanoma, only if the manufacturer provides ipilimumab with the discount agreed in the patient access scheme.

http://www.nice.org.uk/Guidance/TA319

Site by Devopa
© Copyright 2019 NHS. All rights reserved.